Protagenic Therapeutics, Inc.\new Prepaid Expense, Current
Protagenic Therapeutics, Inc.\new (PTIX) had Prepaid Expense, Current of $143.89 thousand as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:PrepaidExpenseCurrent · last filed 2026-08-19
- 2026-06-30: Prepaid Expense, Current $143.89K.
- 2026-03-31: Prepaid Expense, Current $33.41K.
- 2025-12-31: Prepaid Expense, Current $43.79K.
- 2025-09-30: Prepaid Expense, Current $90.64K.
| Period end | Prepaid Expense, Current |
|---|---|
| 2026-06-30 | $143.89K 10-Q · filed 2026-08-19 |
| 2026-03-31 | $33.41K 10-Q · filed 2026-08-19 |
| 2025-12-31 | $43.79K 10-Q · filed 2026-03-09 |
| 2025-09-30 | $90.64K 10-Q · filed 2025-11-26 |
| 2025-06-30 | $135.08K 10-QT · filed 2025-09-10 |
| 2025-03-31 | $55.22K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $44.40K 10-Q · filed 2025-05-13 |
| 2024-09-30 | $366.90K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $444.29K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $43.99K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $144.03K 10-K · filed 2025-03-31 |
| 2023-09-30 | $104.08K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $874.67K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $14.02K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $56.94K 10-K/A · filed 2024-05-14 |
| 2022-09-30 | $101.58K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $146.23K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $12.92K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $688.67K 10-Q · filed 2022-11-14 |
| 2021-09-30 | $802.42K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $129.17K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $4.47K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $208.16K 10-Q · filed 2021-11-15 |
| 2020-09-30 | $13.40K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $6.50K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $31.68K 10-Q · filed 2020-06-18 |
| 2019-12-31 | $43.35K 10-K · filed 2021-03-25 |
| 2019-09-30 | $9.53K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $9.76K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $44.91K 10-Q · filed 2019-05-16 |
| 2018-12-31 | $83.40K 10-K · filed 2020-04-29 |
| 2018-09-30 | $63.95K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $6.04K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $42.29K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $94.54K 10-K · filed 2019-03-29 |
| 2017-09-30 | $114.79K 10-Q · filed 2017-11-13 |
| 2017-03-31 | $24.17K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $60.42K 10-K · filed 2018-04-02 |
| 2016-09-30 | $96.67K 10-Q · filed 2016-11-17 |
| 2015-12-31 | $21.00K 10-Q · filed 2016-03-11 |
| 2015-09-30 | $49.00K 10-Q · filed 2015-11-13 |
| 2015-06-30 | $70.00K 10-Q · filed 2016-03-11 |
| 2015-03-31 | $89.00K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $110.00K 10-Q · filed 2015-02-06 |
| 2014-09-30 | $134.00K 10-Q · filed 2014-11-13 |
| 2014-06-30 | $144.00K 10-K · filed 2015-09-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |